Skip to main content
SSII
NASDAQ Industrial Applications And Services

SS Innovations Q2 Loss Widens to $2.66M; Going Concern Doubt Persists

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.72
Mkt Cap
$738.485M
52W Low
$3.11
52W High
$10
52W Position info
20% above low
Off High info
63% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

SSII sits 20% above its 52-week low of $3.11 on light trading volume (0.3× avg).

Summary

SS Innovations' Q2 loss widened to $2.66M on higher R&D and stock comp, with going concern doubt and material weaknesses still unresolved.

Updates

  1. · FinanceWire — First-half revenue rose 65.6% to $25M; cumulative procedures reached 12,272 including 175 telesurgeries.

  2. · GlobeNewswire — Gross margin fell to 50.9% from 59.1% a year ago, and the company installed 30 systems in Q2, bringing cumulative installations to 224 across twelve countries.


Key Events · Earnings and Guidance · SSII

  • Q2 Loss Widens

    Net loss of $2.66M for Q2 2026 vs $0.26M in Q2 2025; six-month loss $6.24M vs $5.94M.

  • Revenue Growth

    Q2 revenue $13.94M, up 39% YoY; six-month revenue $25.04M, up 66% YoY.

  • Going Concern Doubt

    Management states substantial doubt about ability to continue as a going concern within one year; existing cash insufficient for next 12 months.

  • Material Weaknesses

    Unremediated material weaknesses in internal control over financial reporting, including lack of written documentation and insufficient segregation of duties.


Analysis · SSII · Industrial Applications And Services

SS Innovations reported a Q2 net loss of $2.66 million, up from $0.26 million a year ago, despite revenue growth of 39% to $13.94 million. The loss was driven by a surge in R&D spending for FDA and CE Mark regulatory activities and higher stock-based compensation. The company continues to disclose substantial doubt about its ability to continue as a going concern, and material weaknesses in internal controls remain unremediated. Cash improved to $13.65 million following an $18.45 million private placement in March, but management states existing resources are insufficient for the next twelve months.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SSII was trading at $3.72 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $738.5M. The 52-week trading range was $3.11 to $10.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SSII - Latest Insights

SSII
Oct 13, 2026, 9:26 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.55
Real-time Price: $1.28 info
Change: -$1.27 (-50%) info
Market Cap: $264.632M info
SSII
Oct 13, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.55
Real-time Price: $1.28 info
Change: -$1.27 (-50%) info
Market Cap: $264.632M info
SSII
Oct 09, 2026, 5:08 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $2.65
Real-time Price: $1.28 info
Change: -$1.37 (-52%) info
Market Cap: $264.632M info
SSII
Sep 17, 2026, 12:21 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $3.35
Real-time Price: $1.28 info
Change: -$2.07 (-62%) info
Market Cap: $264.632M info
SSII
Sep 10, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.22
Real-time Price: $1.28 info
Change: -$1.94 (-60%) info
Market Cap: $264.632M info